Meeting
2023 ASCO Annual Meeting
Association of remote, longitudinal patient-reported outcomes (PROs) and step counts with hospitalization or death among patients with advanced cancer undergoing chemotherapy: Secondary analysis of the PROStep randomized trial.
Authors
Ravi Bharat Parikh
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Ravi Bharat Parikh , Emily R Schriver , Joelle Williamson , William Ferrell , Jonathan Wakim , Michael Kopinsky , Mohan Balachandran , Jinbo Chen , Mitesh S Patel , Samuel U Takvorian , Lawrence N. Shulman , Justin E. Bekelman , Ian J Barnett , Christopher Manz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Digital Technology
Clinical Trial Registration Number
NCT04616768
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 1581)
DOI
10.1200/JCO.2023.41.16_suppl.1581
Abstract #
1581
Poster Bd #
175
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy.
First Author: Xin Shelley Wang
Poster
2024 ASCO Annual Meeting
Chemotherapy Care Companion: Enhancing cancer care through digital remote monitoring.
First Author: Erin Pierce
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results.
First Author: Yelena Y. Janjigian
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Patient-reported outcomes in patients with gastrointestinal cancer on oral chemotherapy.
First Author: Kevin Juan Zhang